SEC Filing Form 4: Coleman Mark Acquires 1721 Restricted Stock Units in Axsome Therapeutics, Inc.

On June 5, 2026, Coleman Mark, a director at Axsome Therapeutics, Inc. (AXSM), acquired 1721 Restricted Stock Units (RSUs). The RSUs were granted with a transaction price of $0.00 per share. Each RSU represents a contingent right to receive one share of the Issuer's common stock. These RSUs vest in full on the one-year anniversary of the date of grant. Following this transaction, Coleman Mark holds 1721 shares of common stock underlying the RSUs. The filing is made on Form 4, indicating a transaction by an insider.